CYH · Insider Trading
Community Health Systems, Inc.
Every open-market purchase and sale reported by CYH officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-25 | William Norris Jennings | Director | Sell | −40,000 | −$118.40K |
| 2026-06-01 | David V. Rice | EVP-Clinical Operations & CMO | A | +30,000 | — |
| 2026-04-22 | K Ranga Krishnan | Director | M | +46,950 | — |
| 2026-03-03 | Joseph Arthur Hastings | Director | A | — | — |
| 2026-03-03 | Fawn D Lopez | Director | A | — | — |
| 2026-03-03 | Hubert James Williams | Director | M | +50,595 | — |
| 2026-03-03 | James S. Ely III | Director | M | +50,595 | — |
| 2026-03-03 | Wayne T Smith | Director | G | −19,400 | — |
| 2026-03-03 | Ronald L Burgess Jr | Director | A | — | — |
| 2026-03-03 | K Ranga Krishnan | Director | A | — | — |
| 2026-03-03 | Phillip A. Posey | SVP & CAO | MIXED | +23,812 | −$4.11K |
| 2026-03-03 | Elizabeth T Hirsch | Director | M | +50,595 | — |
| 2026-03-03 | John A Clerico | Director | M | +50,595 | — |
| 2026-03-03 | Kevin A Stockton | EVP, Operations & Development | MIXED | +44,427 | −$123.08K |
| 2026-03-03 | Michael Dinkins | Director | M | +30,662 | — |
| 2026-03-03 | William Norris Jennings | Director | A | — | — |
| 2026-03-03 | Jason K Johnson | EVP & CFO | MIXED | +96,390 | −$81.69K |
| 2026-03-03 | John A Fry | Director | M | +50,595 | — |
| 2026-03-03 | Kevin J Hammons | CEO | MIXED | +259,344 | −$335.26K |
| 2026-03-03 | Susan W Brooks | Director | M | +50,595 | — |
| 2026-03-03 | Justin D Pitt | Pres,Chief Legal&Admin Officer | MIXED | +45,078 | −$86.23K |
| 2025-12-31 | James S. Ely III | Director | M | +2,882 | — |
| 2025-06-02 | Susan W Brooks | Director | M | +5,894 | — |
| 2025-03-03 | William Norris Jennings | Director | A | — | — |
| 2025-03-03 | K Ranga Krishnan | Director | A | — | — |
| 2025-03-03 | John A Clerico | Director | M | +36,556 | — |
| 2025-03-03 | Fawn D Lopez | Director | A | — | — |
| 2025-03-03 | James S. Ely III | Director | M | +36,556 | — |
| 2025-03-03 | Ronald L Burgess Jr | Director | A | — | — |
| 2025-03-03 | Mark B Medley | Regional President | MIXED | +19,818 | −$47.20K |
| 2025-03-03 | Austen D Mason | Regional President | MIXED | +35,500 | — |
| 2025-03-03 | Kevin A Stockton | EVP, Operations & Development | MIXED | +32,131 | −$55.29K |
| 2025-03-03 | Chad A Campbell | Regional President | MIXED | +21,528 | −$42.06K |
| 2025-03-03 | Miguel S Benet | President and CMO | MIXED | −7,365 | −$31.65K |
| 2025-03-03 | Justin D Pitt | Pres,Chief Legal&Admin Officer | MIXED | +34,556 | −$35.35K |
| 2025-03-03 | Tim Hingtgen | CEO | MIXED | +154,793 | −$237.21K |
| 2025-03-03 | Joseph Arthur Hastings | Director | A | — | — |
| 2025-03-03 | Michael Dinkins | Director | M | +36,556 | — |
| 2025-03-03 | Susan W Brooks | Director | M | +30,662 | — |
| 2025-03-03 | Hubert James Williams | Director | M | +36,556 | — |
| 2025-03-03 | Wayne T Smith | Director | M | +30,240 | — |
| 2025-03-03 | John A Fry | Director | M | +36,556 | — |
| 2025-03-03 | Jason K Johnson | SVP & CAO | MIXED | +22,706 | −$37.76K |
| 2025-03-03 | Kevin J Hammons | President and CFO | MIXED | +71,835 | −$130.53K |
| 2025-03-03 | Elizabeth T Hirsch | Director | M | +36,556 | — |
| 2025-02-25 | Miguel S Benet | President and CMO | Sell | −23,875 | −$84.16K |
| 2025-02-21 | Wayne T Smith | Director | G | −20,336 | — |
| 2024-06-03 | Fawn D Lopez | Director | A | — | — |
| 2024-06-03 | Susan W Brooks | Director | M | +5,894 | — |
| 2024-03-15 | Justin D Pitt | EVP and General Counsel | D | −5,001 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Wayne T Smith | Director | 5,699,300 | $16.64M |
| Tim Hingtgen | CEO | 1,467,588 | $4.29M |
| Kevin J Hammons | CEO | 895,545 | $2.61M |
| James S. Ely III | Director | 397,933 | $1.16M |
| John A Clerico | Director | 327,924 | $957.54K |
| Justin D Pitt | Pres,Chief Legal&Admin Officer | 325,256 | $949.75K |
| John A Fry | Director | 249,033 | $727.18K |
| Michael Dinkins | Director | 225,882 | $659.58K |
| Hubert James Williams | Director | 211,863 | $618.64K |
| Kevin A Stockton | EVP, Operations & Development | 208,290 | $608.21K |
| Jason K Johnson | EVP & CFO | 202,049 | $589.98K |
| Elizabeth T Hirsch | Director | 162,059 | $473.21K |
| K Ranga Krishnan | Director | 156,093 | $455.79K |
| Chad A Campbell | Regional President | 150,787 | $440.30K |
| Mark B Medley | Regional President | 144,319 | $421.41K |
| Austen D Mason | Regional President | 117,500 | $343.10K |
| Susan W Brooks | Director | 67,856 | $198.14K |
| Phillip A. Posey | SVP & CAO | 52,924 | $154.54K |
| Miguel S Benet | President and CMO | 47,635 | $139.09K |
| William Norris Jennings | Director | 38,468 | $112.33K |
| David V. Rice | EVP-Clinical Operations & CMO | 30,000 | $87.60K |
| Joseph Arthur Hastings | Director | 17,130 | $50.02K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CYH quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.